Synapse

← Future Lipidology

Papers in Future Lipidology

Page 3 · newest first

  1. Lipids and the endothelium: an updateFuture Lipidology · 2006
  2. Complex genetics of monogenic familial hypercholesterolemiaFuture Lipidology · 2006
  3. Effect of niacin on lipoproteins and atherosclerosisFuture Lipidology · 2006
  4. Antagonism between Type 1 and Type 2 diabetes in unsaturated fatty acid biosynthesisFuture Lipidology · 2006
  5. Sphingolipids in atherosclerosis: a metabolic underpinning of vascular diseaseFuture Lipidology · 2006
  6. Intracellular lipid transport: structure–function relationships in fatty acid binding proteinsFuture Lipidology · 2006
  7. Lipid metabolism in Alzheimer’s and Parkinson’s diseaseFuture Lipidology · 2006
  8. New insights into the regulation of cellular cholesterol efflux and high-density lipoprotein metabolismFuture Lipidology · 2006
  9. Adiposopathy: why do adiposity and obesity cause metabolic disease?Future Lipidology · 2006
  10. Lipid-lowering therapy with statins in postmenopausal women: a few answered and many unanswered questionsFuture Lipidology · 2006
  11. Fibrinolysis and diabetic vascular disease: roles of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitorFuture Lipidology · 2006
  12. The ACTIVATE study: lessons for the future of atherosclerotic therapyFuture Lipidology · 2006
  13. Peroxisome proliferator-activated receptor-ã and lipodystrophyFuture Lipidology · 2006
  14. Cholesteryl ester transfer protein inhibitors: new strategies for raising high-density lipoprotein cholesterolFuture Lipidology · 2006
  15. Noninvasive preclinical assessment of CADFuture Lipidology · 2006
  16. Transport of fatty acids into adipocytesFuture Lipidology · 2006
  17. LDL-apheresis therapy: current therapeutic practice and potential future useFuture Lipidology · 2006
  18. HDL and endothelial function: from molecular mechanisms to clinical observationsFuture Lipidology · 2006
  19. Tracking the dietary cholesterol moleculeFuture Lipidology · 2006
  20. Future directions in reducing hepatic lipotoxicityFuture Lipidology · 2006
  21. Pathways for phosphatidylcholine biosynthesis: targets and strategies for antimalarial drugsFuture Lipidology · 2006
  22. Physiological ligands of PPARs in inflammation and lipid homeostasisFuture Lipidology · 2006
  23. Fasting-induced adipose factor/angiopoietin–like protein 4: a potential target for dyslipidemia?Socio-Environmental Systems Modeling · 2006
  24. Therapeutic modalities following low-density lipoprotein cholesterol goal attainmentFuture Lipidology · 2006
  25. Prominin–1 (CD133): from progenitor cells to human diseasesFuture Lipidology · 2006
  26. Cellular mechanisms of lipodystrophy induction by HIV protease inhibitorsFuture Lipidology · 2006
  27. Liver X receptors: new drug targets to treat Type 2 diabetes?Future Lipidology · 2006
  28. Modification of lipids by reactive oxygen and nitrogen species: the oxy-nitroxy-lipidome and its role in redox cell signalingFuture Lipidology · 2006
  29. Adipokines and the signaling role of adipose tissue in inflammation and obesityFuture Lipidology · 2006
  30. Lipin: a determinant of adiposity, insulin sensitivity and energy balanceFuture Lipidology · 2006
  31. Targeted bioavailability of drugs by triggered release from liposomesFuture Lipidology · 2006
  32. Effects of cardiac rehabilitation on lipoprotein abnormalities in patients with Type 2 diabetes mellitus and metabolic syndromeFuture Lipidology · 2006
  33. Lipid interactions with ion channelsFuture Lipidology · 2006
  34. Liposomal encapsulation enhances the activity of immunostimulatory oligonucleotidesFuture Lipidology · 2006
  35. HDL/apoA-I infusion for atherosclerosis management: an emerging therapeutic paradigmFuture Lipidology · 2006